Abstract: The present disclosure provides for the treatment of wounds, treatment of chronic wounds, treatment of traumatic wounds, treatment of acute wounds, treating or preventing or reducing the risk of a bacterial infection of wounds, inducing blood clotting of a wound, promotion of blood coagulation, promotion of clot formation, promotion of blood clotting by accelerating the normal platelet clotting pathway, promotion of wound healing, promotion of wound occlusion, promotion of wound occlusion thereby reducing scarring, promotion of tissue regeneration, promotion of tissue growth, promotion of tissue growth thereby accelerating wound healing, or a combination thereof, in a subject via the administration of a treated bandage comprising a therapeutically effective amount of an extract of the Croton lechleri tree.

Abstract: The present disclosure provides for a hydrogel formulation comprising a therapeutically effective amount of an extract of the Croton lechleri tree. The present disclosure also provides for a method of treating a dermatological conditon in a subject via the topical administration of a hydrogel formulation comprising a therapeutically effective amount of an extract of the Croton lechleri tree.

Abstract: The present disclosure provides for the treatment of precancerous or cancerous skin lesions via the topical administration of a pharmaceutical composition comprising a therapeutically effective amount of an extract of the Croton lechleri tree. Also provided are details of studies on the effectiveness of an extract of the Croton lechleri tree on precancerous or cancerous skin lesions.

Abstract: The present disclosure provides for a method of treating a bacterial colonization or primary or secondary bacterial infection of an underlying skin disorder in a subject via the topical administration of a pharmaceutical composition comprising a therapeutically effective amount of an extract of the Croton lechleri tree. Additionally the present disclosure provides for a method of treating a bacterial colonization or primary or secondary bacterial infection of the nasal mucosa in a subject via the nasal administration of a pharmaceutical composition comprising a therapeutically effective amount of an extract of the Croton lechleri tree. Also provided are details of studies on the effectiveness of an extract of the Croton lechleri tree on bacterial pathogens.

Abstract: The present disclosure provides for the treatment of acute bacterial skin or skin structure infections via the topical administration of a pharmaceutical composition comprising a therapeutically effective amount of an extract of the Croton lechleri tree. Also provided are details of studies on the effectiveness of an extract of the Croton lechleri tree on acute bacterial skin or skin structure infections and causative pathogens.

Abstract: The present disclosure provides for the treatment cystic fibrosis and/or a bacterial infection in a cystic fibrosis patient via the administration to the lungs via inhalation of a pharmaceutical composition comprising a therapeutically effective amount of an extract of the Croton lechleri tree. Also provided are details of studies on the effectiveness of an extract of the Croton lechleri tree on cystic fibrosis and/or a bacterial infection in a cystic fibrosis patient and causative pathogens.

Abstract: A system and method for accessing and processing auscultatory data and in particular, to a business model that provides on-line services such as storage, retrieval, diagnostic decision support and review of auscultatory data and auscultatory records. A business method is preferably based on a “per use” market model, wherein each “use” of a medical application and related services is treated as a service for which registered and authorized users will make proportional and/or periodic payments based on the requested service(s). Such payments may be in addition to or in lieu of a one-time payment for the purchase of a medical data acquisition device and/or client software, which is associated with the on-line service and which is provided to each registered user for acquiring patient acoustic data.

Abstract: The invention relates to a suction catheter device usable with a respiratory support system which includes a catheter enveloped in a sleeve having a proximal end connector for connection to a suction source through a suction control device such as a suction control valve, and a distal end connector for attachment to a manifold of the respiratory support system. The proximal end connector includes a normally closed valve therein which prevents air flow through the catheter until a suction control device is attached thereto. The proximal end connector may also be adapted for use on a dual lumen catheter and thereby include a fluid injection passage having a one-way check valve therein. The distal end connector of the suction catheter device includes a magnifying window through which a portion of the catheter within the connector can be viewed.

Abstract: A suction catheter device usable with a respiratory support system which includes a catheter enveloped in a sleeve having a proximal end connector for connection to a suction source through a suction control device such as a suction control valve, and a distal end connector for attachment to a manifold of the respiratory support system. The proximal end connector includes a normally closed valve therein which prevents air flow through the catheter until a suction control device is attached thereto. The proximal end connector may also be adapted for use on a dual lumen catheter and thereby include a fluid injection passage having a one-way check valve therein. The distal end connector of the suction catheter device includes a magnifying window through which a portion of the catheter within the connector can be viewed.